n(g)-iminoethylornithine has been researched along with allicin in 1 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (allicin) | Trials (allicin) | Recent Studies (post-2010) (allicin) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 601 | 29 | 339 |
| Protein | Taxonomy | n(g)-iminoethylornithine (IC50) | allicin (IC50) |
|---|---|---|---|
| Mitochondrial 2-oxodicarboxylate carrier | Homo sapiens (human) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, G; Chen, W; Feng, F; Qi, J; Wang, MD; Wang, T; Xiang, M; Xie, WF | 1 |
1 other study(ies) available for n(g)-iminoethylornithine and allicin
| Article | Year |
|---|---|
Neuroprotective effect of allicin against traumatic brain injury via Akt/endothelial nitric oxide synthase pathway-mediated anti-inflammatory and anti-oxidative activities.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Brain Injuries; Chromones; Disulfides; Morpholines; Neuroprotective Agents; Nitric Oxide Synthase Type III; Ornithine; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Sulfinic Acids | 2014 |